Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 20 Polycystic Ovary Syndrome 10 Prostatic Neoplasms 7 Breast Neoplasms 6 Neoplasms 5 Colorectal Neoplasms 4 Insulin Resistance 3 Lung Neoplasms 2 Fatigue 2 Esophageal Neoplasms 2 Cardiotoxicity 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Primary Dysautonomias 1 Pediatric Brain Tumor 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lupus Erythematosus, Systemic 1 Inflammation 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Disease 1 Diabetes Mellitus, Type 1 1 Chemotherapy-Related Cognitive Impairment 1 Cardiovascular Diseases 1

Interventions

Rituximab 301 Cyclophosphamide 241 Peripheral Blood Stem Cell Transplantation 115 fludarabine phosphate 111 Filgrastim 93 Etoposide 85 Radiotherapy 81 Lenalidomide 81 Vincristine 79 Prednisone 79 Mycophenolic Acid 67 Doxorubicin 62 Whole-Body Irradiation 59 Cyclosporine 59 Bendamustine Hydrochloride 59 Melphalan 57 Tacrolimus 54 Busulfan 52 obinutuzumab 50 fludarabine 50 Cytarabine 49 Methotrexate 45 Antilymphocyte Serum 43 Bortezomib 42 Methylprednisolone 37 Carmustine 37 sargramostim 36 ibritumomab tiuxetan 33 ibrutinib 30 Dexamethasone 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Follicular × High-Intensity Interval Training × Clear all

NCT04902092 2023-10-23

BEAT

Monash University

Phase NA Completed

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡